Treatments:Diabetes
From Proteopedia
(Difference between revisions)
| Line 17: | Line 17: | ||
=====Mechanism is not completely understood===== | =====Mechanism is not completely understood===== | ||
*[[Metformin]] - Generic: [[N,N-dimethylbiguanide]] | *[[Metformin]] - Generic: [[N,N-dimethylbiguanide]] | ||
| + | =====Inhibitors of the sodium glucose co-transporter-2 (SGLT-2)===== | ||
| + | *[[Empagliflozin]] | ||
| + | *[[Canagliflozin]] | ||
| + | *[[Dapagliflozin]] | ||
| + | |||
</td> | </td> | ||
</tr> | </tr> | ||
</table> | </table> | ||
Revision as of 12:06, 28 January 2024
Insulin
Dipeptidyl peptidase IV Inhibitor
Peroxisome Proliferator-Activated Receptor Agonist
Glucagon-like peptide-1 (GLP-1) agonist
Mechanism is not completely understood
Inhibitors of the sodium glucose co-transporter-2 (SGLT-2) |
Proteopedia Page Contributors and Editors (what is this?)
Alexander Berchansky, David Canner, Michal Harel, Karsten Theis
